Cost-effectiveness of primary percutaneous coronary intervention versus thrombolytic therapy for acute myocardial infarction

Scandinavian Cardiovascular Journal

Volumn 39, Issue 5, 2005, Pages 276-285

  Selmer, Randi ^a   Halvorsen, Sigrun ^c   Myhre, Kurt I ^b   Wisløff, Torbjørn F ^d   Kristiansen, Ivar Sønbø ^b,d,e  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b Norwegian Health Services Research Centre   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Cost effectiveness; Myocardial infarction; PCI; Primary percutaneous coronary intervention; Revascularization; Thrombolytic therapy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL MALEATE; FUROSEMIDE; METOPROLOL; SIMVASTATIN;

ACUTE HEART INFARCTION; AGED; ARTICLE; CASE REPORT; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FIBRINOLYTIC THERAPY; HEALTH CARE COST; HEALTH STATUS; HEART MUSCLE REPERFUSION; HELICOPTER; HUMAN; LIFE EVENT; LIFE EXPECTANCY; MALE; MORTALITY; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; ST SEGMENT ELEVATION; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; LIFE EXPECTANCY; MALE; MARKOV CHAINS; MIDDLE AGED; MODELS, ECONOMETRIC; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY;

EID: 32144462257     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430510035988     Document Type: Article

References (20)

1. PCI in Acute Myocardial Infarction. SMM-report. 2002;5.
2. Halvorsen, S and Myhre, KI and Steigen, T and Nordrehaug, JE and Gundersen, T and Wiseth, R. (2003) [Primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction?] Tidsskr Nor Laegeforen., 123, pp. 152 - 5.
3. Keeley, EC and Boura, JA and Grines, CL. (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet., 361, pp. 13 - 20.
4. de Boer, MJ and van Hout, BA and Liem, AL and Suryapranata, H and Hoorntje, JC and Zijlstra, F. (1995) A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction Am J Cardiol., 76, pp. 830 - 3.
5. Gibbons, RJ and Holmes, DR and Reeder, GS and Bailey, KR and Hopfenspirger, MR and Gersh, BJ. (1993) Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups N Engl J Med., 328, pp. 685 - 91.
6. Mullner, M and Paulis, M and Nikfardjam, M and Domanovits, H and Huber, K. (1999) Primary PTCA versus thrombolysis with tPA in acute myocardial infarction: A formal cost-effectiveness analysis Wien Klin Wochenschr., 111, pp. 37 - 41.
7. Stone, GW and Grines, CL and Rothbaum, D and Browne, KF and O'Keefe, J and Overlie, PA and (1997) Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: The Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators J Am Coll Cardiol., 29, pp. 901 - 7.
8. Zijlstra, F and Hoorntje, JC and de Boer, MJ and Reiffers, S and Miedema, K and Ottervanger, JP and (1999) Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction N Engl J Med., 341, pp. 1413 - 9.
9. TreeAge Data Pro. Williamstone, MAUS: 2004.
10. Madsen, M and Rasmussen, S and Juel, K. (2000) [Acute myocardial infarction in Denmark. Incidence development and prognosis during a 20-year period] Ugeskr Laeger., 162, pp. 5918 - 23.
11. Rosengren, A and Spetz, CL and Koster, M and Hammar, N and Alfredsson, L and Rosen, M. (2001) Sex differences in survival after myocardial infarction in Sweden; data from the Swedish National Acute Myocardial Infarction Register Eur Heart J., 22, pp. 314 - 22.
12. Peeters, A and Mamun, AA and Willekens, F and Bonneux, L. (2002) A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort Eur Heart J., 23, pp. 458 - 66.
13. Selmer, R and Tverdal, A. (2004) Serum total cholesterol and mortality from ischeamic heart disease, all cardiovascular causes and all causes: 25-year follow-up of the first cardiovascular screening in Finnmark, Oppland and Sogn og Fjordane Nor J Epidemiol., 13, pp. 115 - 25.
14. Wilhelmsen, L and Rosengren, A and Eriksson, H and Lappas, G. (2001) Heart failure in the general population of men-morbidity, risk factors and prognosis J Intern Med., 249, pp. 253 - 61.
15. DRG Price List 2002 and Coding Guide(In Norwegian: Prisliste DRG 2002 med kodeveiledning). Oslo: Ministry of Health; 2002.
16. Fee Schedule for Private Practitioners 2001-2002 as of 1 June 2001(in Norwegian: Normaltariff for privat legepraksis gjeldende fra 1. juni 2001). Oslo: The Norwegian Medical Association; 2001.
17. Hamalainen, H and Maki, J and Virta, L and Keskimaki, I and Mahonen, M and Moltchanov, V and (2004) Return to work after first myocardial infarction in 1991-1996 in Finland Eur J Public Health, 14, pp. 350 - 3.
18. Andersen, HR and Nielsen, TT and Rasmussen, K and Thuesen, L and Kelbaek, H and Thayssen, P and (2003) A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med., 349, pp. 733 - 42.
19. Stone, GW and Ellis, SG and Cox, DA and Hermiller, J and O'Shaughnessy, C and Mann, JT and (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med., 350, pp. 221 - 31.
20. Kristiansen, IS. (2003) Koronare intervensjoner etter 80-årsalderen. [Coronary interventions in octogenarians] Tidsskr Nor Laegeforen., 123, pp. 1735 - 6.